Elisa Agostinetto: Characteristics and clinical outcomes of breast cancer

Elisa Agostinetto shared a post on X, about recent paper published in ESMO Open:

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Authors: E. Agostinetto, M. Bruzzone, A.-S. Hamy, H.J. Kim, C. Chiodi, R. Bernstein-Molho, S. Linn, K. Pogoda, E. Carrasco, F. Derouane, J. Bajpai, G. Nader-Marta, N. Lopetegui-Lia, A.H. Partridge, L. Cortesi, C. Rousset-Jablonski, F. Giugliano, T. Renaud, A. Ferrari, S. Paluch-Shimon, R. Fruscio, W. Cui, S.M. Wong, C. Vernieri, K.J. Ruddy, M.V. Dieci, A. Matikas, M. Rozenblit, D. Aguilar y Mendez, L. De Marchis, R. Borea, F. Puglisi, M. Pistelli, J. Kufel-Grabowska, R. Di Rocco, E. Mariamidze, F. Atzori, H.R. Kourie, L. Popovic, E. de Azambuja, E. Blondeaux, M. Lambertini.

”Now out in ESMO Open our study on characteristics and clinical outcomes of breast cancer in a world cohort of 4,628 young BRCA carriers DNA, according to tumor histology.

1. Low incidence of lobular, having higher disease stage and more BRCA.
2. Pathogenic Variants (PVs).”

Source: Elisa Agostinetto/X

Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute. Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.